For detailed Complete Peptide Storage Protocol access our Guide
Stock up on antioxidant treats
Published clinical research has characterised the compound in controlled trials: a Phase 2 obesity trial reported dose-dependent body-weight change in the study population (Jastreboff et al., 2023), and a separate Phase 2 trial investigated the GIP/GLP-1/glucagon agonist in people with type 2 diabetes (Rosenstock et al., 2023)
PubMed: 21184799 Growth Hormone Fragment Peptide-Induced Lipolysis: Comparison of AOD 9604, HGH, and Thiazolidinediones in vitro Liu X, Ng FM, Shen Y, et al
Ask us any questions about Neurobion.
Know when to seek prompt care o Contact your clinician if you notice fatigue, bruising, jaundice, abdominal pain, or unexplained weight loss